In IPF, rs35705950, a MUC5B promoter variant, was discovered to disrupt a CpG motif, resulting in a significant increase in MUC5B expression by inhibiting DNA methylation [22]. Here, MUC5B is linked to idiopathic pulmonary fibrosis.